A compact review of progress and prospects of deep learning in drug discovery
- PMID: 36976427
- DOI: 10.1007/s00894-023-05492-w
A compact review of progress and prospects of deep learning in drug discovery
Abstract
Background: Drug discovery processes, such as new drug development, drug synergy, and drug repurposing, consume significant yearly resources. Computer-aided drug discovery can effectively improve the efficiency of drug discovery. Traditional computer methods such as virtual screening and molecular docking have achieved many gratifying results in drug development. However, with the rapid growth of computer science, data structures have changed considerably; with more extensive and dimensional data and more significant amounts of data, traditional computer methods can no longer be applied well. Deep learning methods are based on deep neural network structures that can handle high-dimensional data very well, so they are used in current drug development.
Results: This review summarized the applications of deep learning methods in drug discovery, such as drug target discovery, drug de novo design, drug recommendation, drug synergy, and drug response prediction. While applying deep learning methods to drug discovery suffers from a lack of data, transfer learning is an excellent solution to this problem. Furthermore, deep learning methods can extract deeper features and have higher predictive power than other machine learning methods. Deep learning methods have great potential in drug discovery and are expected to facilitate drug discovery development.
Keywords: Deep learning; Drug design; Drug discovery; Drug reaction; Drug repositioning; Recommendation system.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Artificial intelligence to deep learning: machine intelligence approach for drug discovery.Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3. Epub 2021 Apr 12. Mol Divers. 2021. PMID: 33844136 Free PMC article. Review.
-
Structure-based drug design with geometric deep learning.Curr Opin Struct Biol. 2023 Apr;79:102548. doi: 10.1016/j.sbi.2023.102548. Epub 2023 Feb 24. Curr Opin Struct Biol. 2023. PMID: 36842415 Review.
-
Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.Methods Mol Biol. 2021;2190:167-184. doi: 10.1007/978-1-0716-0826-5_7. Methods Mol Biol. 2021. PMID: 32804365 Review.
-
A Structure-Based Drug Discovery Paradigm.Int J Mol Sci. 2019 Jun 6;20(11):2783. doi: 10.3390/ijms20112783. Int J Mol Sci. 2019. PMID: 31174387 Free PMC article. Review.
-
Deep Learning in Structure-Based Drug Design.Methods Mol Biol. 2022;2390:261-271. doi: 10.1007/978-1-0716-1787-8_11. Methods Mol Biol. 2022. PMID: 34731473
Cited by
-
Digital intelligence technology: new quality productivity for precision traditional Chinese medicine.Front Pharmacol. 2025 Apr 8;16:1526187. doi: 10.3389/fphar.2025.1526187. eCollection 2025. Front Pharmacol. 2025. PMID: 40264673 Free PMC article. Review.
-
Improved Prediction of Ligand-Protein Binding Affinities by Meta-modeling.J Chem Inf Model. 2024 Dec 9;64(23):8684-8704. doi: 10.1021/acs.jcim.4c01116. Epub 2024 Nov 22. J Chem Inf Model. 2024. PMID: 39576762 Free PMC article.
-
Role of artificial intelligence in revolutionizing drug discovery.Fundam Res. 2024 May 9;5(3):1273-1287. doi: 10.1016/j.fmre.2024.04.021. eCollection 2025 May. Fundam Res. 2024. PMID: 40528990 Free PMC article. Review.
References
-
- Morro A, Canals V, Oliver A, Alomar ML, Galan-Prado F, Ballester PJ, Rossello JL (2018) A stochastic spiking neural network for virtual screening. IEEE Trans Neural Netw Learn Syst 29(4):1371–1375. https://doi.org/10.1109/TNNLS.2017.2657601 - DOI - PubMed
-
- Singh N, Chaput L, Villoutreix BO (2021) Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace. Brief Bioinform 22(2):1790–1818. https://doi.org/10.1093/bib/bbaa034 - DOI - PubMed
-
- Filer DL, Kothiya P, Setzer RW, Judson RS, Martin MT (2017) tcpl: the ToxCast pipeline for high-throughput screening data. Bioinformatics 33(4):618–620. https://doi.org/10.1093/bioinformatics/btw680 - DOI - PubMed
-
- Lloyd MD (2020) High-throughput screening for the discovery of enzyme inhibitors. J Med Chem 63(19):10742–10772. https://doi.org/10.1021/acs.jmedchem.0c00523 - DOI - PubMed
-
- Potdar S, Ianevski A, Mpindi JP, Bychkov D, Fiere C, Ianevski P, Yadav B, Wennerberg K, Aittokallio T, Kallioniemi O, Saarela J, Ostling P (2020) Breeze: an integrated quality control and data analysis application for high-throughput drug screening. Bioinformatics 36(11):3602–3604. https://doi.org/10.1093/bioinformatics/btaa138 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- 22078073/National Natural Science Foundation of China
- GUANGXI AA18242040/Guangxi Innovation-Driven Development Special Fund Project
- GUANGXI AB18221121/Guangxi Key Research and Development Program
- guizhongzhongkai201703/Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards Research
- No. kx201703/Guangxi Key Laboratory of Trusted Software, Guilin University of Electronic Technology
LinkOut - more resources
Full Text Sources